N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine

C130H134ClF10N35O5 — CID 158515421

IUPACN-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
SMILESCc1cccc(CC2(Nc3nc(N4CCOCC4)nc(-n4c(C(F)F)nc5ccccc54)n3)CC2)c1.Cc1ccccc1CC1(Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3Cl)CC2)nc(N2CCOCC2)n1
InChIInChI=1S/C27H29F2N7O.3C26H27F2N7O.C25H24ClF2N7O/c28-22(29)23-30-20-10-4-5-11-21(20)36(23)26-32-24(31-25(33-26)35-14-16-37-17-15-35)34-27(12-6-7-13-27)18-19-8-2-1-3-9-19;1-17-5-4-6-18(15-17)16-26(9-10-26)33-23-30-24(34-11-13-36-14-12-34)32-25(31-23)35-20-8-3-2-7-19(20)29-22(35)21(27)28;1-17-6-2-3-7-18(17)16-26(10-11-26)33-23-30-24(34-12-14-36-15-13-34)32-25(31-23)35-20-9-5-4-8-19(20)29-22(35)21(27)28;27-21(28)22-29-19-9-4-5-10-20(19)35(22)25-31-23(30-24(32-25)34-13-15-36-16-14-34)33-26(11-6-12-26)17-18-7-2-1-3-8-18;26-17-6-2-1-5-16(17)15-25(9-10-25)33-22-30-23(34-11-13-36-14-12-34)32-24(31-22)35-19-8-4-3-7-18(19)29-21(35)20(27)28/h1-5,8-11,22H,6-7,12-18H2,(H,31,32,33,34);2-8,15,21H,9-14,16H2,1H3,(H,30,31,32,33);2-9,21H,10-16H2,1H3,(H,30,31,32,33);1-5,7-10,21H,6,11-17H2,(H,30,31,32,33);1-8,20H,9-15H2,(H,30,31,32,33)
InChIKeyHLOJLXLWRVSBBB-UHFFFAOYSA-N
MW2492.17 g/mol
LogP23.30
Rot. Bonds35

About N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine

N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine (PubChem CID 158515421) has the molecular formula C130H134ClF10N35O5 and a molecular weight of 2492.17 g/mol. Its IUPAC name is N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine.

Molecular Properties

Compound NameN-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
PubChem CID158515421
Molecular FormulaC130H134ClF10N35O5
Molecular Weight2492.17 g/mol
Exact Mass2490.08
IUPAC NameN-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
SMILESCc1cccc(CC2(Nc3nc(N4CCOCC4)nc(-n4c(C(F)F)nc5ccccc54)n3)CC2)c1.Cc1ccccc1CC1(Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3Cl)CC2)nc(N2CCOCC2)n1
InChIInChI=1S/C27H29F2N7O.3C26H27F2N7O.C25H24ClF2N7O/c28-22(29)23-30-20-10-4-5-11-21(20)36(23)26-32-24(31-25(33-26)35-14-16-37-17-15-35)34-27(12-6-7-13-27)18-19-8-2-1-3-9-19;1-17-5-4-6-18(15-17)16-26(9-10-26)33-23-30-24(34-11-13-36-14-12-34)32-25(31-23)35-20-8-3-2-7-19(20)29-22(35)21(27)28;1-17-6-2-3-7-18(17)16-26(10-11-26)33-23-30-24(34-12-14-36-15-13-34)32-25(31-23)35-20-9-5-4-8-19(20)29-22(35)21(27)28;27-21(28)22-29-19-9-4-5-10-20(19)35(22)25-31-23(30-24(32-25)34-13-15-36-16-14-34)33-26(11-6-12-26)17-18-7-2-1-3-8-18;26-17-6-2-1-5-16(17)15-25(9-10-25)33-22-30-23(34-11-13-36-14-12-34)32-24(31-22)35-19-8-4-3-7-18(19)29-21(35)20(27)28/h1-5,8-11,22H,6-7,12-18H2,(H,31,32,33,34);2-8,15,21H,9-14,16H2,1H3,(H,30,31,32,33);2-9,21H,10-16H2,1H3,(H,30,31,32,33);1-5,7-10,21H,6,11-17H2,(H,30,31,32,33);1-8,20H,9-15H2,(H,30,31,32,33)
InChIKeyHLOJLXLWRVSBBB-UHFFFAOYSA-N
XLogP23.30
TPSA404.95 Ų
H-Bond Donors5
H-Bond Acceptors40
Rotatable Bonds35
Heavy Atoms181
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002492.17
LogP ≤ 523.30
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1040

Analyze N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine?
The IUPAC name of N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine (CID 158515421) is N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine.
What is the SMILES notation for N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine?
The canonical SMILES for N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine is Cc1cccc(CC2(Nc3nc(N4CCOCC4)nc(-n4c(C(F)F)nc5ccccc54)n3)CC2)c1.Cc1ccccc1CC1(Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3)CCCC2)nc(N2CCOCC2)n1.FC(F)c1nc2ccccc2n1-c1nc(NC2(Cc3ccccc3Cl)CC2)nc(N2CCOCC2)n1.
What is the InChIKey of N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine?
The InChIKey is HLOJLXLWRVSBBB-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H29F2N7O.3C26H27F2N7O.C25H24ClF2N7O/c28-22(29)23-30-20-10-4-5-11-21(20)36(23)26-32-24(31-25(33-26)35-14-16-37-17-15-35)34-27(12-6-7-13-27)18-19-8-2-1-3-9-19;1-17-5-4-6-18(15-17)16-26(9-10-26)33-23-30-24(34-11-13-36-14-12-34)32-25(31-23)35-20-8-3-2-7-19(20)29-22(35)21(27)28;1-17-6-2-3-7-18(17)16-26(10-11-26)33-23-30-24(34-12-14-36-15-13-34)32-25(31-23)35-20-9-5-4-8-19(20)29-22(35)21(27)28;27-21(28)22-29-19-9-4-5-10-20(19)35(22)25-31-23(30-24(32-25)34-13-15-36-16-14-34)33-26(11-6-12-26)17-18-7-2-1-3-8-18;26-17-6-2-1-5-16(17)15-25(9-10-25)33-22-30-23(34-11-13-36-14-12-34)32-24(31-22)35-19-8-4-3-7-18(19)29-21(35)20(27)28/h1-5,8-11,22H,6-7,12-18H2,(H,31,32,33,34);2-8,15,21H,9-14,16H2,1H3,(H,30,31,32,33);2-9,21H,10-16H2,1H3,(H,30,31,32,33);1-5,7-10,21H,6,11-17H2,(H,30,31,32,33);1-8,20H,9-15H2,(H,30,31,32,33).
What are the key properties of N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine?
N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine has a molecular weight of 2492.17 g/mol, XLogP of 23.30, 35 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-benzylcyclobutyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-(1-benzylcyclopentyl)-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;N-[1-[(2-chlorophenyl)methyl]cyclopropyl]-4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(2-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[1-[(3-methylphenyl)methyl]cyclopropyl]-6-morpholin-4-yl-1,3,5-triazin-2-amine is sourced from PubChem (CID 158515421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).